| P50 | author | Sarah Spiegel | Q20950329 |
| | Natasha A Karp | Q30511243 |
| | Iain C Macaulay | Q42317797 |
| | Tobias Bald | Q43117864 |
| | Anneliese O Speak | Q46442616 |
| | Thierry Voet | Q91106775 |
| P2093 | author name string | Mark J Arends | |
| | David J Adams | |
| | Simon Clare | |
| | Antonella Galli | |
| | Elizabeth Tuck | |
| | Diane Gleeson | |
| | Kim Wong | |
| | Thomas Tüting | |
| | Edward Ryder | |
| | Louise van der Weyden | |
| | Hannah Wardle-Jones | |
| | Sanger Mouse Genetics Project | |
| | Andrew D Campbell | |
| | Emma L Cambridge | |
| | Martin Del Castillo Velasco-Herrera | |
| | Nicola Griggs | |
| P2860 | cites work | Bioconductor: open software development for computational biology and bioinformatics | Q21194861 |
| | Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis | Q24529958 |
| | Genome-wide generation and systematic phenotyping of knockout mice reveals new roles for many genes | Q24597048 |
| | The role of sphingosine-1-phosphate transporter Spns2 in immune system function | Q24599540 |
| | The role of sphingosine-1-phosphate in endothelial barrier function | Q26862336 |
| | Export of sphingosine-1-phosphate and cancer progression | Q27009557 |
| | Sphingosine-1-phosphate receptor 1 signalling in T cells: trafficking and beyond | Q27011857 |
| | PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells | Q28243975 |
| | IRF-7 is the master regulator of type-I interferon-dependent immune responses | Q28511410 |
| | Gray platelet syndrome: proinflammatory megakaryocytes and α-granule loss cause myelofibrosis and confer metastasis resistance in mice | Q28512818 |
| | The sphingosine-1-phosphate transporter Spns2 expressed on endothelial cells regulates lymphocyte trafficking in mice | Q28588851 |
| | Spns2, a transporter of phosphorylated sphingoid bases, regulates their blood and lymph levels, and the lymphatic network | Q28591658 |
| | RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement | Q28594711 |
| | Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research | Q29547313 |
| | Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 | Q29547403 |
| | HTSeq--a Python framework to work with high-throughput sequencing data | Q29614489 |
| | STAR: ultrafast universal RNA-seq aligner | Q29615052 |
| | Microenvironmental regulation of tumor progression and metastasis | Q29615504 |
| | Integrative data analysis: the simultaneous analysis of multiple data sets | Q33457534 |
| | Lymphatic endothelial cell sphingosine kinase activity is required for lymphocyte egress and lymphatic patterning | Q33615222 |
| | Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate. | Q33773569 |
| | CD39/ENTPD1 expression by CD4+Foxp3+ regulatory T cells promotes hepatic metastatic tumor growth in mice | Q34091467 |
| | The S1P(1)-mTOR axis directs the reciprocal differentiation of T(H)1 and T(reg) cells. | Q34217756 |
| | P-Rex1 is required for efficient melanoblast migration and melanoma metastasis | Q34235334 |
| | Critical steps in hematogenous metastasis: an overview. | Q34267607 |
| | Full-length RNA-seq from single cells using Smart-seq2. | Q34395363 |
| | Impact of temporal variation on design and analysis of mouse knockout phenotyping studies | Q34401154 |
| | Targeted inhibition of mitochondrial Hsp90 suppresses localised and metastatic prostate cancer growth in a genetic mouse model of disease. | Q34628001 |
| | Smart-seq2 for sensitive full-length transcriptome profiling in single cells. | Q34993864 |
| | Functional and molecular characterisation of EO771.LMB tumours, a new C57BL/6-mouse-derived model of spontaneously metastatic mammary cancer | Q35144029 |
| | The role of nicotinamide adenine dinucleotide phosphate oxidase-derived reactive oxygen species in the acquisition of metastatic ability of tumor cells | Q35221860 |
| | Spontaneous mutation of the Dock2 gene in Irf5-/- mice complicates interpretation of type I interferon production and antibody responses | Q35889350 |
| | Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accomp | Q36375152 |
| | Communication between host organism and cancer cells is transduced by systemic sphingosine kinase 1/sphingosine 1-phosphate signalling to regulate tumour metastasis. | Q36386459 |
| | The transporter Spns2 is required for secretion of lymph but not plasma sphingosine-1-phosphate | Q39589659 |
| | An improved Flp deleter mouse in C57Bl/6 based on Flpo recombinase | Q39699570 |
| | Antigen specificity determines the pro- or antitumoral nature of CD8+ T cells. | Q39763772 |
| | Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages | Q40306295 |
| | Correction of Defects Responsible for Impaired Qa-2 Class Ib MHC Expression on Melanoma Cells Protects Mice from Tumor Growth | Q40653237 |
| | Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration | Q40900789 |
| | A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene | Q46098688 |
| | Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients | Q46265539 |
| | Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma | Q46279328 |
| | Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor | Q46927225 |
| | A sharper Bonferroni procedure for multiple tests of significance | Q56622251 |
| | p110γ and p110δ Phosphoinositide 3-Kinase Signaling Pathways Synergize to Control Development and Functions of Murine NK Cells | Q57184702 |
| | Requirement for IRF-1 in the microenvironment supporting development of natural killer cells | Q59098134 |
| | The sphingosine-1-phosphate receptor agonist FTY720 and its phosphorylated form affect the function of CD4+CD25+ T cells in vitro | Q84108192 |
| P433 | issue | 7636 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 233-236 | |
| P577 | publication date | 2017-01-04 | |
| P1433 | published in | Nature | Q180445 |
| P1476 | title | Genome-wide in vivo screen identifies novel host regulators of metastatic colonization | |
| P478 | volume | 541 | |